Article
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
Human pathology - 1 Jun 2009
Santarpia Libero, Sherman Steven I, Marabotti Anna, Clayman Gary L, El-Naggar Adel K
Abstract excerpt
To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also identified a previously unknown (novel) mutation in the activation kinase domain of the BRAF (A598V), replacing alanine with valine. Functional analysis showed that this mutation led to the up-regulation of the BRAF kinase activity and its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
